- Home
- Publications
- Publication Search
- Publication Details
Title
PD-1/PD-L1 blockade in renal cell cancer
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 13, Issue 1, Pages 77-84
Publisher
Informa UK Limited
Online
2016-07-18
DOI
10.1080/1744666x.2016.1214575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
- (2016) Melanie Ruf et al. INTERNATIONAL JOURNAL OF CANCER
- Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
- (2016) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel technologies and emerging biomarkers for personalized cancer immunotherapy
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
- (2015) Laurence Albiges et al. EUROPEAN JOURNAL OF CANCER
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
- (2015) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour and patient factors in renal cell carcinoma—towards personalized therapy
- (2015) Ahmed Q. Haddad et al. Nature Reviews Urology
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
- (2015) Roberto Iacovelli et al. Targeted Oncology
- Potential of New Therapies like Anti-PD1 in Kidney Cancer
- (2014) Anasuya Gunturi et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Renal cell carcinoma
- (2014) E. Jonasch et al. BMJ-British Medical Journal
- PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
- (2014) L.B. Jilaveanu et al. Journal of Cancer
- Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors
- (2014) Christel Devaud et al. OncoImmunology
- Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
- (2013) J. M. Simon et al. GENOME RESEARCH
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
- (2013) Andrew M. Intlekofer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Risk Factors for Renal Cell Carcinoma in the VITAL Study
- (2013) Liam C. Macleod et al. JOURNAL OF UROLOGY
- The Molecular Biology of Renal Cell Carcinoma
- (2013) Stephen M. Keefe et al. SEMINARS IN ONCOLOGY
- Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
- (2013) Simone P. Sittig et al. OncoImmunology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cigarette Smoking Is Associated With Advanced Renal Cell Carcinoma
- (2011) Matvey Tsivian et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
- (2010) Bradley C. Leibovich et al. JOURNAL OF UROLOGY
- Spontaneous regression of renal cell carcinoma lung metastases in a patient with psoriasis
- (2009) Bohuslav Melichar et al. ACTA ONCOLOGICA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
- (2008) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started